| Dr Youlan Tang, MD | |
|
320 Pomfret St, Putnam, CT 06260-1836 | |
| (860) 928-6541 | |
| Not Available |
| Full Name | Dr Youlan Tang |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 320 Pomfret St, Putnam, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154789840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 66168 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Day Kimball Hospital | Putnam, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Day Kimball Medical Group Inc | 1557514411 | 60 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
Focusing on ease of use for routine applications, the latest cellSens software release, version 1.8, offers flexible and user-centric imaging, processing, analysing and reporting. New and enhanced functions include a fully customisable user interface, precise frame-by-frame sample navigation and easy one-button switching between wells.
People who work long hours are at a greater risk of stroke and coronary heart disease than people who work a standard week, according to the largest study of the issue to date, published in The Lancet.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 1 days ago
| Entity Name | Day Kimball Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376813972 PECOS PAC ID: 1557514411 Enrollment ID: O20130102000091 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
Focusing on ease of use for routine applications, the latest cellSens software release, version 1.8, offers flexible and user-centric imaging, processing, analysing and reporting. New and enhanced functions include a fully customisable user interface, precise frame-by-frame sample navigation and easy one-button switching between wells.
People who work long hours are at a greater risk of stroke and coronary heart disease than people who work a standard week, according to the largest study of the issue to date, published in The Lancet.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Youlan Tang, MD 320 Pomfret Street, Csb #@, Putnam, CT 06260-1836 Ph: (860) 928-6541 | Dr Youlan Tang, MD 320 Pomfret St, Putnam, CT 06260-1836 Ph: (860) 928-6541 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
Focusing on ease of use for routine applications, the latest cellSens software release, version 1.8, offers flexible and user-centric imaging, processing, analysing and reporting. New and enhanced functions include a fully customisable user interface, precise frame-by-frame sample navigation and easy one-button switching between wells.
People who work long hours are at a greater risk of stroke and coronary heart disease than people who work a standard week, according to the largest study of the issue to date, published in The Lancet.
The diabetes drug metformin continues to expand beyond its treatment for type 2 diabetes. In addition to its potential use in treating age-related health problems, metformin can treat portal hypertension—high blood pressure in the liver resulting from cirrhosis, according to a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 1 days ago
Timothy E Cooper, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Pomfret Street, Putnam, CT 06260 Phone: 860-928-2736 Fax: 860-928-6367 | |
Mukti J Patel-prineas, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 Pomfret St, Putnam, CT 06260 Phone: 860-963-7917 Fax: 860-963-0018 | |
Gerald Bland Sullivan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7 Kennedy Dr, Putnam, CT 06260 Phone: 860-928-6541 Fax: 860-928-8268 | |
Charles L Wreschner, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 235 Pomfret St, Putnam, CT 06260 Phone: 860-928-0493 Fax: 860-928-9255 | |
Dr. Dominick F Roto Ii, DO FAAFP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 Pomfret St, Putnam, CT 06260 Phone: 860-928-5248 Fax: 860-928-5286 | |
Dr. Rosemary Ijeoma Maduka, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Pomfret St, Putnam, CT 06260 Phone: 860-928-2736 |